ச U கிுஓங் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MedCity News Evox has big pharma partners. Now it has $95M to bring its own drugs to the clinic In the past year, Evox Therapeutics has inked alliances with two big pharma companies. The Series C financing now positions the biotech to advance to the clinic with its own exosome-based therapies. Shares0   Cells in the body share material via tiny vesicles that shuttle between them, carrying molecular payloads from one cell to another. Evox Therapeutics is developing medicines that leverage this mechanism as way of accessing cells and tissues that are beyond the reach of current drug technologies. The biotech has research partnerships with two large pharmaceutical companies. Now it has $95.4 million to advance into clinical testing with several rare disease drug candidates. Redmile Group led the Series C round of funding.

United kingdomRed mileChau khuongCodiak biosciencesEli lillyOxford sciences innovationKarolinska instituteRedmile groupOxford universityUnited kingdom based evoxTakeda pharmaceuticalMassachusetts based codiak biosciencesCowen healthcareWeight lossMedical devicesHealthcare innovation